PMID- 22355790 OWN - NLM STAT- MEDLINE DCOM- 20130412 LR - 20211021 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 2 DP - 2012 TI - A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals. PG - 280 LID - 10.1038/srep00280 [doi] LID - 280 AB - Various methods for the direct reprogramming of human somatic cells have been developed. However, a therapeutic method to reprogram and eliminate human solid tumor cells has not been developed. Here we show a novel therapeutic method to reprogram and eliminate human solid tumor cells with chemicals. This therapeutic method may be applicable to various human solid tumor cells that express aldo-keto reductase family 1 member B10 (AKR1B10) and retinoid X receptors (RXRs). FAU - Moriguchi, Hisashi AU - Moriguchi H FAU - Zhang, Yue AU - Zhang Y FAU - Mihara, Makoto AU - Mihara M FAU - Sato, Chifumi AU - Sato C LA - eng PT - Journal Article PT - Retracted Publication DEP - 20120221 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Retinoid X Receptors) RN - 0 (Retinoids) RN - EC 1.1.1.- (AKR1B10 protein, human) RN - EC 1.1.1.- (Aldo-Keto Reductases) RN - EC 1.1.1.21 (Aldehyde Reductase) SB - IM RIN - Sci Rep. 2012;2:839. PMID: 23326632 MH - Aldehyde Reductase/metabolism MH - Aldo-Keto Reductases MH - Carcinoma, Hepatocellular/enzymology/metabolism/*pathology MH - Humans MH - Liver Neoplasms/enzymology/metabolism/*pathology MH - Liver Transplantation MH - Oxygen Consumption MH - Retinoid X Receptors/metabolism MH - Retinoids/*pharmacology PMC - PMC3282982 EDAT- 2012/02/23 06:00 MHDA- 2012/02/23 06:01 PMCR- 2012/02/21 CRDT- 2012/02/23 06:00 PHST- 2011/09/14 00:00 [received] PHST- 2011/12/23 00:00 [accepted] PHST- 2012/02/23 06:00 [entrez] PHST- 2012/02/23 06:00 [pubmed] PHST- 2012/02/23 06:01 [medline] PHST- 2012/02/21 00:00 [pmc-release] AID - srep00280 [pii] AID - 10.1038/srep00280 [doi] PST - ppublish SO - Sci Rep. 2012;2:280. doi: 10.1038/srep00280. Epub 2012 Feb 21.